MentionFox
Home › funding signals › Potentiam Biosciences, Inc.
Form D · on the record

Potentiam Biosciences — $250K Form D filing, November 2026

Before you sell to, join or invest in Potentiam Biosciences, Inc.

MentionFox check on Potentiam Biosciences, Inc.: only 1 source on file so far (checked 18 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/potentiam-biosciences-inc-form-d-000002

Check Potentiam Biosciences, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Potentiam Biosciences, Inc.?

Potentiam Biosciences, Inc. filed a Form D with the Securities and Exchange Commission on 2026-11-16.

Potentiam Biosciences, Inc. filed a Form D notice of an exempt securities offering with the SEC on November 16, 2026. The filing reports $250K sold. Its industry group is Biotechnology. It names Bruce Beutler (Sole Director; Chairman, President and Secretary), Peppi Prasit (Chief Executive Officer), Xinzhu Wang (Treasurer) (SEC Form D, November 16, 2026).

Sell to companies like Potentiam Biosciences, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Potentiam Biosciences, Inc. raised on Nov 16. 137 companies raised this week.

Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.

Linework USA INC.$1.2BAI and software
Linework USA INC.$326MAI and software
Pathos AI, Inc.$238MBiotech
Galvanize Therapeutics, Inc.$136MBiotech
Tractian Inc.$106MAI and software
Check one company free All companies that raised this week

5 more Biotechnology raises in Texas within 90 days ↓

Selling to Potentiam Biosciences, Inc.? See who runs it and how to reach them, plus this week's 161 other newly funded companies.

Is this your company?

Key facts

Run the free check on Potentiam Biosciences, Inc. →

Potentiam Biosciences, Inc.

New Form D on file · 2026-11-16 · the record

$250K
raise on the record
D
filing
1
investors in
TEXAS
based
Open the record →

What the record says

FilingForm D
Filed2026-11-16
Industry groupBiotechnology
Entity typeCorporation
Incorporated inDELAWARE
Year formed2024
BasedIRVING, TEXAS
CIK2164266
Accession0002164266-26-000002

Pitching, partnering or investing alongside them? See who really runs and owns Potentiam Biosciences, Inc.

Free to see. No signup.

Keep reading

More on the people and the money behind Potentiam Biosciences, Inc., from the filings we hold.

More raises like this

Biotechnology raises by companies based in Texas, filed within 90 days of this one, largest first.

What do you want to do with Potentiam Biosciences, Inc.?

Get the full cited report on Potentiam Biosciences, Inc.

What the filing shows about Potentiam Biosciences, Inc.

  • 1 investor had already put money in when it filed.
  • The filing names 3 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Potentiam Biosciences, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

Just raised? Your investors will ask for updates.

The weeks after a raise are when investors, other founders and press look Potentiam Biosciences, Inc. up. FoxPlug is your startup's chief of staff: it reads your whole stack and tells you what to fix, what to say and what to skip, for founders shipping with Claude Code, Codex or Cursor. It drafts your monthly investor update from your real numbers, and its free tools need no account. GetFoxChat puts an AI operator on Potentiam Biosciences, Inc.'s own site, named as you like, so the visitors this record sends you don't read one page and leave.

Who the filing names, and in what role

The filing gives Potentiam Biosciences, Inc.'s address as 5605 N. Macarthur Blvd., 10TH Floor, Office 1039, Irving, TX 75038.

What the filing says

  • Offered: an open-ended amount (the filing says Indefinite). Sold: $250,000. Left to sell: open-ended (Indefinite). (filing)
  • Investors: 1 had already invested. (filing)
  • Date of first sale: November 3, 2026. (filing)
  • Types of securities: Options, warrants or other rights to acquire another security; Securities to be acquired on exercise of an option, warrant or other right; Other: Simple Agreement for Future Equity (SAFE). (filing)
  • Item 16: the filing reports that none of the proceeds goes to executive officers, directors or promoters. (filing)

This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.

Order the Full Report on Potentiam Biosciences, Inc. See pricing

Is Potentiam Biosciences, Inc. a real, registered company?

Potentiam Biosciences, Inc. is a registered filer with the SEC (CIK 2164266) and has filed since 2026-11-16. 1 filing is on record, the latest on 2026-11-16.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

Who runs Potentiam Biosciences, Inc.?

Potentiam Biosciences, Inc.'s Form D of 2026-11-16 names Bruce Beutler, Peppi Prasit and Xinzhu Wang as its officers, directors or promoters.

How much has Potentiam Biosciences, Inc. raised?

Its new offerings report $250K sold across 1 offering, as its own filings state.

Biotechnology · by week
This raise, $250K, filed week of Nov 16

Trailing twelve months. 758 filings in Biotechnology, totalled by week. The dot is this raise, $250K, on the same scale — one filing against the whole group's total, so it sits low by construction.

Want the whole picture on Potentiam Biosciences, Inc.?

What the filing shows about Potentiam Biosciences, Inc.

  • 1 investor had already put money in when it filed.
  • The filing names 3 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Potentiam Biosciences, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Potentiam Biosciences, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Sourced from the filing index on sec.gov.

RSS

Tools for this story

Each opens in a new tab, filled in for Potentiam Biosciences, Inc.. With no account yet, you sign up free and land on the result.

Share this page

Is this your company?

Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

Potentiam Biosciences, Inc.: Raised $250K, Form D filed 2026-11-16
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/potentiam-biosciences-inc-form-d-000002
Last updated 2026-11-18
Primary record: SEC filing 1 · SEC filing 2
Potentiam Biosciences raised $250K — SEC Form D filing, November 2026. MentionFox, 2026-11-18. https://mentionfox.com/funding/potentiam-biosciences-inc-form-d-000002